I2I
NVO

Insight 2811 Inc’s Novo Nordisk NVO Stock Holding History

Insight 2811 Inc’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-17,066
Closed -$459K – 98
2016
Q2 		$459K Sell
17,066
-1,490
-8% -$40.9K 0.18% 79
2016
Q1 		$503K Sell
18,556
-1,140
-6% -$30.5K 0.2% 75
2015
Q4 		$572K Hold
19,696
– – 0.27% 65
2015
Q3 		$534K Sell
19,696
-24
-0.1% -$680 0.31% 63
2015
Q2 		$540K Buy
19,720
+1,358
+7% +$38.2K 0.26% 72
2015
Q1 		$490K Buy
+18,362
New +$423K 0.23% 83

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return

Insight 2811 Inc's NVO Position: Q3 2016 in Review

Insight 2811 Inc sold out of Novo Nordisk (NVO) in Q3 2016, closing a stake of 17,066 shares — an estimated $459K sold.

Insight 2811 Inc first reported a position in NVO in Q1 2015 and held it in 6 quarters. The position peaked at $572K in Q4 2015. 513 funds tracked by Wall St. Rank hold NVO as of Q3 2016.

  • Insight 2811 Inc reported no remaining Novo Nordisk position as of Q3 2016 after selling out during the quarter.
  • Insight 2811 Inc sold 17,066 Novo Nordisk shares in Q3 2016, an estimated $459K.
  • Insight 2811 Inc first reported a position in Novo Nordisk in Q1 2015 and held it in 6 quarters.
  • Insight 2811 Inc's Novo Nordisk position peaked at $572K in Q4 2015.
  • 513 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2016.

Based on Insight 2811 Inc's 13F filing for Q3 2016, filed 25 Oct 2016.